Table 4.
Experimental validation of Xap_SSRs through ePCR or eMapping across the eight Xap genomes
| Sl. no | Different Xap strains evaluated for ePCR | e PCR validation of XAP_SSRs primers across genomes | |||||
|---|---|---|---|---|---|---|---|
| Allele no | |||||||
| Number of LMG859 primers got validated | One | Two | Three | ≥ Four | Total (%) | ||
| 1 | LMG859 | 2927 | 545 (18.62%) | 931 (31.81%) | 1230 (42.02%) | 221 (7.55%) | 100 |
| 2 | LMG7439 | 2904 | 546 (18.80%) | 933 (32.13%) | 1214 (41.80%) | 211 (7.27%) | 100 |
| 3 | LMG7504 | 2903 | 550 (18.95%) | 924 (31.83%) | 1216 (41.89%) | 213 (7.34%) | 100 |
| 4 | BD0022 | 2916 | 551(18.90%) | 901 (30.90%) | 1251 (42.90%) | 213 (7.30%) | 100 |
| 5 | BD0023 | 2916 | 558 (19.14%) | 894 (30.66%) | 1251 (42.90%) | 213 (7.30%) | 100 |
| 6 | BD0025 | 2916 | 542 (18.59%) | 936 (32.10%) | 1224 (41.98%) | 214 (7.34%) | 100 |
| 7 | Bagalkot | 2884 | 522 (18.10%) | 920 (31.90%) | 1242 (43.07%) | 200 (6.93%) | 100 |
| 8 | NCPPB3563 | 2885 | 524 (18.16%) | 921 (31.92%) | 1227 (42.53%) | 213 (7.38%) | 100 |
| Average | 2906 | 542 | 920 | 1232 | 212 | ||